FDA Approves Novel Prostate Cancer “Vaccine”
The treatment, which works by turning the body’s immune system against invading cancer cells, is called Provenge and is manufactured by Seattle biotech firm Dendreon
Read more on Time Magazine
FDA Approves Novel Prostate Cancer “Vaccine”
The treatment, which works by turning the body’s immune system against invading cancer cells, is called Provenge and is manufactured by Seattle biotech firm Dendreon
Read more on Time Magazine
Product Description
Michio Kushi’s macrobiotic blueprint for the prevention and relief of disease.
U of L reaches out to rural area in fight with cancer
After surgery, chemotherapy and radiation, 38-year-old Owensboro, Ky., resident Jennifer Slone is cancer free — and she credits her survival to a gynecological oncologist, a women’s cancer specialist who treated her through a University of Louisville program that reaches out to Western Kentucky.
Read more on Louisville Courier-Journal